Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03015246 · ClinicalTrials.gov registry record · Phase 1
Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence
A Phase 1 study, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT03015246 is a Phase 1 study that has completed, run by Wayne State University. The registered enrollment target is 26 participants.
The verdict
NCT03015246, a Phase 1 study, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This research deals with behaviors that are part of opioid dependence. The purpose is to study how stress and medication dose can affect opioid drug use.
Interventions
- DRUG Extended release morphine
- DRUG Buprenorphine/Naloxone low dose
- DRUG Buprenorphine/Naloxone moderate dose
- DRUG Buprenorphine/Naloxone high dose
- DRUG Active stressor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2016-12 |
| Est. Completion | 2020-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03015246
The ClinicalTrials.gov registry entry for NCT03015246 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Extended release morphine is the first listed.
NCT03015246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03015246 about?
NCT03015246 is a clinical study titled "Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence". This research deals with behaviors that are part of opioid dependence. The purpose is to study how stress and medication dose can affect opioid drug use.
What is the current status of trial NCT03015246?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2016-12. Estimated completion is 2020-08.
What interventions are being tested in trial NCT03015246?
The interventions under investigation include: Extended release morphine (DRUG), Buprenorphine/Naloxone low dose (DRUG), Buprenorphine/Naloxone moderate dose (DRUG), Buprenorphine/Naloxone high dose (DRUG), Active stressor (DRUG).
Who is sponsoring clinical trial NCT03015246?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.